Abstract
The Niemann-Pick type C is a rare neurodegenerative disease that results from loss-of-function point mutations in NPC1 or NPC2, which affect the homeostasis of sphingolipids and sterols in human cells. We have previously shown that yeast lacking Ncr1, the orthologue of human NPC1 protein, display a premature ageing phenotype and higher sensitivity to oxidative stress associated with mitochondrial dysfunctions and accumulation of long chain bases. In this study, a lipidomic analysis revealed specific changes in the levels of ceramide species in ncr1Δ cells, including decreases in dihydroceramides and increases in phytoceramides. Moreover, the activation of Sit4, a ceramide-activated protein phosphatase, increased in ncr1Δ cells. Deletion of SIT4 or CDC55, its regulatory subunit, increased the chronological lifespan and hydrogen peroxide resistance of ncr1Δ cells and suppressed its mitochondrial defects. Notably, Sch9 and Pkh1-mediated phosphorylation of Sch9 decreased significantly in ncr1Δsit4Δ cells. These results suggest that phytoceramide accumulation and Sit4-dependent signaling mediate the mitochondrial dysfunction and shortened lifespan in the yeast model of Niemann-Pick type C1, in part through modulation of the Pkh1-Sch9 pathway.
Keywords: Niemann-Pick type C, ceramide, sphingolipid signaling, mitochondria, Sit4, Sch9
Graphical Abstract

1. Introduction
Sphingolipids are important structural components of cell membranes, highly conserved among species, and their bioactive metabolites can act as signaling molecules regulating many biological processes. Sphingosine, a long chain sphingoid base (LCB), and ceramide are involved in the regulation of actin cytoskeleton organization, endocytosis, apoptosis, cell senescence and cell cycle arrest whereas sphingosine-1-phosphate plays a key role in proliferation, mitogenesis, cell migration, cell survival and inflammation (reviewed in [1, 2]). The homeostasis of sphingolipids is affected in several age-associated neurological diseases, such as Alzheimer’s [3] and Parkinson’s [4] diseases, in cancer [5], as well as in sphingolipidoses, a group of lysosomal storage diseases that comprise several distinct defects in lysosomal enzymes and lipid transfer proteins [6]. A characteristic feature of the sphingolipidoses is the accumulation of other secondary storage products because of the lipid nature of the primary storage compound, leading to a traffic jam [7]. Niemann-Pick type C (NPC) is a sphingolipidosis caused by loss-of-function point mutations in NPC1 or NPC2 gene [8, 9] and is clinically characterized by a severe neurodegeneration and accentuated failure of systemic organs such as liver and spleen. The NPC1 protein is a large transmembrane protein that is located in the transient late endosome/lysosome system, while NPC2 protein is a soluble glycoprotein with high affinity for cholesterol [10, 11]. Both proteins seem to be involved in intracellular transport of endocytosed cholesterol through the endolysosomal system [12]. In addition to cholesterol accumulation concomitant with sphingomyelin and gangliosides storage [13], there is an increase in the levels of sphingosine that precedes cholesterol entrapment in the lysosome of NPC1 cells [14].
Sphingolipid metabolism is highly conserved from yeast to mammalian and has been extensively studied using this simple model organism (Fig. 1) [15]. We have recently reported that yeast cells lacking Ncr1, an orthologue of human NPC1 [16], exhibit high levels of sphingosine and hyperactivation of the Pkh1-Sch9 pathway that are associated with severe mitochondrial dysfunctions, oxidative stress sensitivity and premature ageing [17]. Several studies suggest that sphingolipid homeostasis plays an important role in oxidative stress resistance and longevity in yeast, as also described in mammals [18, 19]. Lag1, a component of ceramide synthase, regulates replicative lifespan [20, 21]. Yeast cells lacking Ydc1, a dihydroceramidase that hydrolyzes dihydroceramide into the LCB dihydrosphingosine, exhibit an increased chronological lifespan (CLS) whereas cells overexpressing YDC1 show mitochondria and vacuolar fragmentation, increased apoptosis and a shortened CLS [22]. The levels of LCBs increase in stationary phase cells due to a decrease in the activity of both ceramide synthase (Lag1) and LCB kinase (Lcb4) [23], and the down-regulation of sphingolipid synthesis extends CLS in part due to a reduction in LCB-mediated activation of Sch9 [24], the yeast homologue of mammalian ribosomal protein S6 kinase (S6K) also related to Akt/protein kinase B [25, 26]. Moreover, yeast lacking Isc1, an orthologue of mammalian neutral sphingomyelinase-2 (nSMase2) that generates ceramide through the hydrolysis of inositol phosphosphingolipids, display a shortened CLS, oxidative stress sensitivity, mitochondrial dysfunction, iron overload and caspase-dependent apoptosis [27].
Figure 1. Schematic representation of sphingolipid metabolism in yeast.
Metabolic intermediates and genes encoding the most important enzymes involved in each step of sphingolipid synthesis and turnover are shown.
Defects in NPC1 function result in the accumulation of ceramide in the liver of NPC1 patients [28]. In addition, the deficiency of a NPC1-related protein in the intracellular parasite Toxoplasma increases the accumulation of cholesteryl esters, sphingomyelin, as well as of ceramide [29]. In mammals, changes in ceramide levels have been implicated in apoptosis through the modulation of signaling proteins [30, 31], including protein kinase C (PKC), cathepsin D, JNK, ceramide-activated protein kinases and ceramide-activated protein phosphatases (CAPPs) [32–35]. The CAPPs are found in all eukaryotes and are composed by one catalytic subunit and two regulatory subunits [36]. The yeast CAPP is constituted by the Tpd3 and Cdc55 regulatory subunits and by the Sit4 catalytic subunit [37, 38]. Sit4 is a serine-threonine protein phosphatase with high homology to human protein phosphatase 6 [39]. It has been implicated in the regulation of the cell cycle [40], mitochondrial function [41–43], carbohydrate metabolism [44, 45], homeostasis of monovalent ion and pH [46], the Pkc1-MAPK pathway [47] and traffic from the ER to the Golgi complex [48]. Moreover, Sit4 is down regulated by the Target of Rapamycin Complex 1 (TORC1) [49, 50]. Interestingly, a recent study implicated NPC1 in mTORC1 regulation in response to lysosomal cholesterol. Castellano et al showed that lysosomal cholesterol drives mTORC1 recruitment to lysosomes and activation. Moreover, NPC1 mediates mTORC1 inhibition upon cholesterol depletion and mTORC1 is constitutively active in NPC1 deleted cells [51].
Our laboratory has shown that SIT4 deletion increases CLS and H2O2 resistance through modulation of mitochondrial function [52]. Moreover, we reported that Hog1 MAPK is a downstream effector of Sit4 that regulates mitochondrial function, being activated in response to ceramide by a Sch9-dependent mechanism [53, 54]. Both Sch9 and Sit4 are also modulators of sphingolipid metabolism [55, 56]. These results support a functional cross talk between Sit4 and Sch9 in response to ceramide changes.
In this report, we show that the activation of Sit4/CAPP associated with an increase in the levels of long chain phytoceramide species impairs oxidative stress resistance, mitochondrial function and chronological lifespan in ncr1Δ cells. Notably, the suppression of ncr1Δ phenotypes by SIT4 deletion is associated with downregulation of the Pkh1-Sch9 pathway.
2. Materials and methods
2.1. Yeast strains and growth conditions
The Saccharomyces cerevisiae strains used in this work are listed in table 1. The growth media used were YPD [1 % (w/v) yeast extract, 2 % (w/v) bactopeptone, 2 % (w/v) glucose], YPG [1 % (w/v) yeast extract, 2 % (w/v) bactopeptone, 2 % (v/v) glycerol], synthetic complete (SC) drop-out medium containing 2 % (w/v) glucose 0.67 % yeast nitrogen base without amino acids or minimal medium containing 2 % (w/v) glucose 0.67 % yeast nitrogen base without amino acids supplemented with appropriate amino acids [0.008 % (w/v) histidine, 0.04 % (w/v) leucine, 0.008 % (w/v) tryptophan)] and 0.008 % (w/v) uracil. Yeast cells were grown aerobically at 26 °C in an orbital shaker (at 140 rpm), with a ratio of flask volume:medium volume of 5:1, to early exponential phase (OD600nm=0.6) or to post-diauxic shift phase (PDS; OD600nm=7–9).
Table 1.
S. cerevisiae strains used in this work.
| Strain | Genotype | Source |
|---|---|---|
| BY4741 | Mata, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 | EUROSCARF |
| ncr1Δ::KanMX4 | BY4741 ncr1Δ::KanMX4 | [17] |
| ncr1Δ::URA3 | BY4741 ncr1Δ::URA3 | [17] |
| sit4Δ | BY4741 sit4Δ::KanMX4 | EUROSCARF |
| ncr1Δ::URA3 sit4Δ::KanMX4 | BY4741 ncr1Δ::URA3 sit4Δ::KanMX4 | This study |
| sit4Δ::HIS3 | BY4741 sit4Δ::HIS3 | This study |
| ncr1Δ::KanMX4 sit4Δ::HIS3 | BY4741 ncr1Δ::KanMX4 sit4Δ::HIS3 | This study |
| cdc55Δ | BY4741 cdc55Δ::KanMX4 | EUROSCARF |
| ncr1Δ::URA3 cdc55Δ::KanMX4 | BY4741 ncr1Δ::URA3 cdc55Δ::KanMX4 | This study |
| cdc55Δ::HIS3 | BY4741 cdc55Δ::HIS3 | This study |
| ncr1Δ::KanMX4 cdc55Δ::HIS3 | BY4741 ncr1Δ::KanMX4 cdc55Δ::HIS3 | This study |
| sur2Δ | BY4741 sur2Δ::KanMX4 | EUROSCARF |
| sur2Δ::KanMX4 ncr1Δ::URA3 | BY4741 sur2Δ::KanMX4 ncr1Δ::URA3 | This study |
| sur2Δ::HIS3 | BY4741 sur2Δ::HIS3 | This study |
| sur2Δ::HIS3 ncr1Δ::KanMX4 | BY4741 sur2Δ::HIS3 ncr1Δ::KanMX4 | This study |
| BY4741 LAG1-9MYC | BY4741 LAG1-9MYC::hphNT1 | [55] |
| ncr1Δ LAG1-9MYC | ncr1Δ::URA3 LAG1-9MYC::hphNT1 | This study |
| BY4741 YPC1-9MYC | BY4741 YPC1-9MYC::hphNT1 | [55] |
| ncr1Δ YPC1-9MYC | ncr1Δ::URA3 YPC1-9MYC::hphNT1 | This study |
| lcb4Δ | BY4741 lcb4Δ::KanMX4 | EUROSCARF |
| ncr1Δ lcb4Δ | BY4741 ncr1Δ::URA3 lcb4Δ::KanMX4 | This study |
| sit4Δlcb4Δ | BY4741 sit4::HIS3 lcb4Δ::KanMX4 | This study |
| ncr1Δ sit4Δ lcb4Δ | BY4741 ncr1Δ::URA3 sit4::HIS3 lcb4Δ::KanMX4 | This study |
Deletion strains were generated using PCR-derived deletion cassettes containing URA3, HIS3 or KanMX4 with flanking regions of each gene. Yeast cells were transformed using the lithium acetate/single-stranded DNA/polyethylene glycol protocol [57].
To evaluate the levels of Lag1 and Ypc1 expression, ncr1Δ LAG1-9MYC and ncr1Δ YPC1-9MYC cells were generated by disruption of the NCR1 gene in BY4741 cells with LAG1 and YPC1 genomically tagged with 9Myc, respectively [55] All the disruptions were confirmed by standard PCR procedures.
Plasmids used in this work are detailed in table 2. To study Sit4-Gln3-dependent MEP2 expression, yeast cells were transformed with the YCpMEP2-lacZ plasmid [58] and selected in minimal medium lacking uracil. To assess mitochondrial morphology, cells were transformed with pYX222-mtDsRed plasmid [59] and selected in minimal medium lacking histidine. To evaluate the expression of ceramide synthases and ceramidases, cells were transformed with plasmids expressing lacZ reporter fusions of the promoters of LAG1, LAC1, YDC1 and YPC1 genes [55] and selected in minimal medium lacking uracil.
Table 2.
Plasmids used in this work.
| Strain | Insert | Marker | Reference |
|---|---|---|---|
| YCpMEP2-lacZ | MEP2 promoter (−828/+27) | URA3 | [58] |
| pYX222-mtDsRed | Mitochondrial matrix targeted-DsRed | HIS3 | [59] |
| YEp357-LAC1- lacZ | LAC1 promoter (−780/+18) | URA3 | [55] |
| YEp357-LAG1- lacZ | LAG1 promoter (−780/+30) | URA3 | [55] |
| YEp357-YDC1- lacZ | YDC1 promoter (−750/+30) | URA3 | [55] |
| YEp357-YPC1- lacZ | YPC1 promoter (−750/+30) | URA3 | [55] |
2.2 Sphingolipid analysis by HPLC-MS/MS
Yeast cells were grown in SC-glucose medium and 1.9×109 cells were collected at exponential and PDS phase. Cell pellets were re-suspended in 1mL of lipid extraction solvent: 50 % (v/v) isopropanol, 10 % (v/v) diethyl ether, 2 % (v/v) pyridine, 25 % (v/v) ammonia. A 200 μL volume of glass beads were added into a 2 mL screw cup plastic tubes. Tubes were shaken in a bead beater 5 times, 3 min on, 1 min off at 4 °C. The content of the tubes was poured into a 13×100 mm glass tubes. An additional 1 mL solvent was used to wash the plastic tubes and was added into the glass tubes. The tubes containing 2 mL solvent with cells and glass beads were dried in an analytical nitrogen evaporator (N-EVAP). The dried samples were sent to the Lipidomic Core at the Medical University of South Carolina for lipid analysis. Levels of dihydroceramides, phytoceramides, α-hydroxylated phytoceramides, long-chain sphingoid bases and their phosphorylated forms were measured by the high-performance liquid chromatography/mass spectrometry (LC-MS/MS) methodology as previously described [60]. Analytical results of lipids were expressed as pmol sphingolipid/total cell number.
2.3. Oxidative stress resistance and chronological lifespan
For analysis of oxidative stress resistance, yeast cells were grown to exponential phase and treated with 1.5 mM H2O2 for 1 h. CLS was assayed as previously described [61]. Briefly, overnight cultures were diluted to OD600nm=0.6 and grown for 24 h (PDS phase) or 48 h (stationary phase; considered t0 in the lifespan assay) and kept in culture media at 26 °C. Cell viability was determined by standard dilution plate counts on YPD medium containing 1.5 % (w/v) agar. Colonies were counted after growth for 3 days at 26 °C. Viability was expressed as a percentage of colony-forming units in relation to time 0 or to untreated cells, as indicated.
2.4. Enzymatic activities
All the procedures were carried out at 4 °C. Yeast cells were grown to respiratory phase and harvested by centrifugation. Cytochrome c oxidase (COX) activity was determined as previously described [62], by measuring cytochrome c oxidation. For the β-galactosidase assay, yeast cells were grown in selective SC-glucose medium to PDS phase, and the activity was measured as previously described [52], with some modifications: a cellular extract was prepared in 100 mM Tris-HCl, 1 mM DTT, 10 % (v/v) glycerol, and 150 μg of total protein was used in the assay.
2.5. Oxygen consumption and growth in glycerol
Oxygen consumption rate was measured for 3×108 cells at 26 °C in phosphate buffer using an oxygen electrode (Oxygraph, Hansatech). Data were analyzed using the Oxyg32 v2.25 software. For analysis of respiratory capacity, yeast cells were grown to exponential phase, diluted to an OD600nm=0.1 and five-fold serial dilutions were plated in SC media containing glucose or glycerol (non-fermentable carbon source) supplemented with 1.5 % (w/v) agar.
2.6. Mitochondrial morphology
Mitochondrial morphology was analyzed in cells transformed with a plasmid expressing mitochondrial DsRed (pYX222-mtDsRed) [59]. Cells were grown in SC-glucose medium lacking histidine to PDS phase. The mitochondrial network was observed in live cells mounted on agarose coated slides by fluorescence microscopy (AxioImager Z1, Carl Zeiss). Data image stacks were deconvolved by QMLE algorithm of Huygens Professional v3.0.2p1 (Scientific Volume Imaging B.V.). Maximum intensity projection was used to output final images using ImageJ 1.51n software. Final scientific figures were designed using Figure J tool.
2.7. Protein extraction and western blotting analysis
Yeast cells were grown in SC-glucose medium to exponential phase and protein extracts were prepared as described [24] with minor modifications. Briefly, 9×108cells were collected, suspended in 200 μL of water and 200 μL of 0.2 M NaOH. Samples were vortexed and incubated at room temperature for 5 min, centrifuged and the pellet was suspended in sample buffer and boiled for 5 min at 95 °C. Equal amounts of protein (BCA™ Protein Assay Kit quantification) were loaded onto SDS-PAGE and transferred onto a nitrocellulose membrane (GE Healthcare). Detection of the proteins was performed with the primary antibodies: mouse anti-yeast phosphoglycerate kinase (Pgk1) antibody (1:30000, Molecular Probes), rabbit anti-Sit4 antibody (1:5000, kindly provided by Dr Yu Jiang), mouse anti-c-myc antibody (1:100, Roche), rabbit anti-Sch9 antibody (1:1000, kindly provided by Dr Robert Dickson) or rabbit anti-P-T570-Sch9 antibody (1:10000, kindly provided by Dr Robbie Loewith), and with the secondary antibody, anti-mouse IgG-peroxidase (1:5000, Molecular probes) or anti-rabbit IgG-peroxidase (1:5000, Sigma). Immunodetection was performed by chemiluminescence (Advansta).
2.8. Statistical analysis
The results were represented by mean and standard deviation values of at least three independent experiments. Statistical analyses were carried out using GraphPad Prism Software v6.02 (GraphPad Software).
3. Results
3.1. Ceramide levels in Ncr1-deficient cells
In order to characterize changes in the levels of ceramide species associated with NCR1 deletion, a lipidomic analysis was performed in cells grown to post diauxic shift (PDS) phase (respiratory phase). At this phase, ncr1Δ mutant cells present mitochondrial dysfunction associated with the fragmentation of the mitochondrial network [17]. The levels of long chain (LC; C12 to C22) and very long chain (VLC; C24 to C26) dihydroceramides, phytoceramides and α-hydroxylated phytoceramides were measured.
The total levels of dihydroceramides (dhCer) were 40% lower in ncr1Δ cells (Fig. 2A–B) due to a decrease in the levels of most (C18- to C26) dhCer species (Fig. S1A–B). Concerning phytoceramides (phytoCer), the levels of C14- to C20-species were 2-fold higher in ncr1Δ cells comparing with parental levels (Fig. S1C–D), but no major differences were observed for VLC phytoCer (Fig. 2C–D). Notably, the levels of C14- to C20 phytoCer also increased in ncr1Δ cells grown to exponential phase (data not shown). These results show significant changes in ceramide levels, including an increase of long chain phytoCer and a decrease of dhCer species in cells lacking Ncr1.
Figure 2. Levels of dihydroceramide and phytoceramide species.
S. cerevisiae BY4741, ncr1Δ, sit4Δ and ncr1Δsit4Δ cells were grown in SC-glucose medium to post-diauxic shift (PDS) phase. Levels of long chain ceramides (C14 to C22) and very long chain ceramides (C24 to C26) were measured by HPLC-MS/MS as described in Material and Methods. Data are expressed as pmol of lipid per total cell number (1.9×109) and are mean ± variance of three independent experiments.
We postulated that the mitochondrial defects of ncr1Δ cells could result from a decrease in α-hydroxylated phytoceramides (αOH-phytoCer), which are particularly enriched in mitochondria [63]. However, the levels of LC αOH-phytoCer were slightly higher in Ncr1-deficient cells (Supplementary Fig. S1E–F). Thus, the mitochondrial dysfunction displayed by ncr1Δ cells does not seem to result from a decrease in αOH-phytoCer, but we cannot rule-out the hypothesis that a decrease of these species may occur specifically in mitochondria of ncr1Δ cells.
To assess changes in the expression of genes related to ceramide synthesis and turnover, namely ceramidases (YPC1 and YDC1) and ceramide synthases (LAG1 and LAC1), BY4741 and ncr1Δ cells were transformed with lacZ reporters under the control of those gene promoters. The ncr1Δ cells displayed an increase in reporter activity for YPC1 and YDC1 (Fig. 3A) as well as for LAC1 and LAG1 (Fig. 3B). However, the induction of LAG1 (10-fold) was much higher than those observed for the other genes (3–4-fold). We also evaluated changes in Lag1 and Ypc1 levels in BY4741 and ncr1Δ cells expressing 9Myc tagged LAG1 and YPC1. Consistent with the induction of LAG1 expression, the levels of Lag1-9Myc increased significantly in ncr1Δ cells (Fig. 3C), but the increase of Ypc1-9Myc levels was mild (Fig. 3D). These results suggest that upregulation of ceramide synthases in exponential phase may contribute to the accumulation of phytoCer in ncr1Δ cells in log and PDS phase. The concomitant induction of ceramidases, which hydrolyze ceramides, probably explains the accumulation of LCBs in this mutant [17].
Figure 3. Expression of ceramidases and ceramide synthases in Ncr1-deficient cells.
(A, B) S. cerevisiae BY4741 and ncr1Δ cells were transformed with lacZ reporter plasmids expressing the promotors of ceramidases genes YDC1 and YPC1 (A) and ceramide synthases genes LAG1 and LAC1 (B). Cells were grown in SC-glucose medium lacking uracil to log phase and the transcriptional activation of these genes were measured by β-galactosidase activity. ****p<0.0001 relative to BY4741; Two-way ANOVA and Bonferroni test. (C, D) Analysis of Lag1 and Ypc1 levels in BY4741 and ncr1Δ cells expressing 9Myc tagged LAG1 and YPC1. Protein extracts were separated by SDS–PAGE and blotted into a nitrocellulose membrane, and tagged proteins were detected using an anti-Myc antibody. Pgk1 was used as loading control. One representative experiment out of three is shown for (C) Lag1-9Myc and (D) Ypc1-9Myc. The quantification of Myc band intensities (normalized for Pgk1) is shown.
3.2. Activation of CAPP is associated with oxidative stress sensitivity, premature ageing and mitochondrial dysfunctions of Ncr1 deficient cells
Besides structural functions, ceramide is known to regulate cellular processes through modulation of signaling pathways [1]. Yeast cells present a CAPP composed of two regulatory subunits, Tpd3 and Cdc55, and the catalytic subunit Sit4 that is stimulated by ceramide [37, 38, 56]. Thus, we postulated that accumulation of phytoceramide species in ncr1Δ cells could mediate cell responses by activation of the Sit4 phosphatase [38]. Sit4 regulates the dephosphorylation of Gln3 transcription factor, leading to its translocation to the nucleus [64]. To assess Sit4 activation, we measured the Gln3-dependent MEP2 expression in BY4741, ncr1Δ, sit4Δ, ncr1Δsit4Δ, cdc55Δ, and ncr1Δcdc55Δ cells transformed with a MEP2-lacZ reporter [58]. In addition, Sit4 levels were analyzed by Western blotting. At PDS phase, β-galactosidase activity increased 2.8-fold in ncr1Δ cells (relative to BY4741), and this effect was suppressed by SIT4 or CDC55 deletion (Fig. 4A). The levels of Sit4 were similar in ncr1Δ cells and decreased by deletion of CDC55 (Fig. 4B). We also assessed β-galactosidase activity in cells depleted for Sur2, a sphinganine C4-hydroxylase responsible for conversion of dihydrosphingosine to phytosphingosine and dihydroceramide to phytoceramide. Notably, deletion of SUR2 led to a decrease of β-galactosidase in ncr1Δ cells (Fig. 4A) but this decrease was not as marked as that associated with SIT4 deletion. These results suggest that CAPP activation increases in Ncr1-deficient cells, in part due to an increase of phytoceramide levels, with no major changes in Sit4 expression.
Figure 4. Sit4 activation increases in Ncr1 deficient cells and mediates oxidative stress sensitivity and premature ageing.
(A) S. cerevisiae BY4741, ncr1Δ, sit4Δ and ncr1Δsit4Δ, cdc55Δ and ncr1Δcdc55Δ cells expressing a Sit4-Gln3-dependent MEP2-LacZ reporter were grown to post-diauxic shift phase in SC-glucose medium lacking uracil. (A) β-galactosidase activity was measured as described in Material and Methods. ***p<0.001; One-way ANOVA and Bonferroni test. (B) Immunoblot analysis of Sit4 levels in cells grown to PDS. Pgk1 was used as loading control. A representative experiment out of three is shown. (C) Cells were grown to exponential phase (O.D.600nm=0.6) in SC-glucose medium and exposed to 1.5 mM H2O2 for 1 h. Cellular viability was measured as the percentage of the colony-forming unit (treated cells vs non-stressed cells). ***p<0.001, relative to ncr1Δ; One-way ANOVA and Bonferroni test. (D) Cells were grown to PDS phase and maintained in the growth medium overtime. Cellular viability was measured at 2 to 3 days intervals and was expressed as % colony forming units (aged vs day 0).
Next, we assessed if Sit4 activation by phytoceramides contributes to the oxidative stress sensitivity and shortened CLS of ncr1Δ cells. As previously described [52], hydrogen peroxide resistance and CLS were higher in sit4Δ as well as cdc55Δ single mutants in comparison with parental cells. Notably, deletion of SIT4 or CDC55 suppressed the hydrogen peroxide sensitivity and reversed the shortened CLS of ncr1Δ cells (Fig. 4C–D).
Sit4 negatively regulates mitochondrial function [42, 52] and ncr1Δ cells also present severe mitochondrial defects [17]. Thus, we hypothesized that an increase of CAPP activity could be associated with mitochondrial dysfunctions displayed by this mutant. To test this hypothesis, we analyzed mitochondrial functionality in BY4741, ncr1Δ, sit4Δ, ncr1Δsit4Δ, cdc55Δ and ncr1Δcdc55Δ cells. Our results show that deletion of SIT4 or CDC55 led to a reversal of the low oxygen consumption rate, low cytochrome c oxidase (COX) activity and growth defect on a non-fermentable carbon source (glycerol) exhibited by ncr1Δ cells (Fig. 5A–C). Notably, the deletion of SUR2 in ncr1Δ cells also restored oxygen consumption and growth on glycerol plates and increased CLS (Fig. S2). This is consistent with the hypothesis that CAPP activation by phytoceramides contributes to mitochondrial dysfunction in ncr1Δ cells.
Figure 5. SIT4 and CDC55 disruption suppresses mitochondrial dysfunctions exhibited by ncr1Δ cells.
(A, B) S. cerevisiae cells were grown in SC-glucose medium to post-diauxic shift phase. Oxygen consumption rates (A) and cytochrome c oxidase (COX) specific activity (B) were measured. **p<0.01 and ***p<0.001, relative to ncr1Δ; One-way ANOVA and Bonferroni test. (C) Cells were grown to exponential phase and fivefold serial dilutions were plated in SC solid medium containing glucose or glycerol as carbon source. One representative experiment out of three is shown. (D) Yeast cells transformed with pYX222-mtDsRed (expressing mitochondrial DsRed) were visualized by fluorescence microscopy. One representative experiment out of three is shown. Scale bar: 5 μm.
To get further insights on mitochondrial function, we also assessed the integrity of the mitochondrial network by fluorescence microscopy using cells expressing a mitochondria matrix-targeted peptide fused to DsRed (Fig 5D). Our results show that the punctate pattern exhibited by ncr1Δ cells, indicative of mitochondrial network fragmentation, was suppressed by SIT4 or CDC55 deletion, with double mutant cells displaying a normal tubular mitochondrial network. The overall findings indicate that CAPP activation in ncr1Δ cells contributes to an impairment of mitochondrial dynamics and functionality, leading to a decrease in oxidative stress resistance and chronological lifespan.
3.3. Levels of sphingolipids in sit4Δ and ncr1Δsit4Δ cells
The regulation of sphingolipid metabolism is highly complex, and it may involve feedback mechanisms controlled by signaling proteins modulated by bioactive sphingolipids. Thus, we postulated that the suppression of ncr1Δ phenotypes upon SIT4 deletion could be associated with the modulation of sphingolipid homeostasis. To test this hypothesis, ceramide levels were measured in sit4Δ and ncr1Δsit4Δ cells grown to PDS phase.
Our results show that the levels of LC dhCer decreased about 50 % in sit4Δ cells when compared to parental cells (Fig. 2A). Although there was an increase of C16-dhCer species, the levels of C18:1-, C20-, C20:1-, C22- and C22:1-dhCer, which are the most abundant dhCer species, decreased about 2-fold in sit4Δ cells (Fig. S1A). These results are consistent with a previous report showing that total dhCer levels decrease in sit4Δ cells [56]. Interestingly, deletion of SIT4 in ncr1Δ cells increased C18- to C22-dhCer content to parental levels. Concerning VLC dhCer, sit4Δ cells displayed an increase in the levels of C24-dhCer (Fig. S1B) and SIT4 deletion suppressed the lower levels of VLC dhCer exhibited by ncr1Δ cells (Fig. 2B).
Notably, SIT4 deletion had major effects on phytoCer. The levels of LC (C14- to C22-) phytoCer were significantly higher (more than 3-fold) in sit4Δ and ncr1Δsit4Δ cells compared to parental or ncr1Δ cells (Fig. 2C; Fig. S1C). In contrast, the levels of C26- and C26:1-phytoCer (the most abundant species) decreased almost 3-fold in sit4Δ cells (Fig. 2D; Fig. S1D), which is consistent with the reduction of total phytoCer previously described for this mutant [56]. Regarding αOH-phytoCer, similar changes were observed: the levels of most LC species increased in sit4Δ and ncr1Δsit4Δ cells whereas αOH-phyto-C26-Cer decreased (Supplementary Fig. S1E–F).
These findings suggest that Sit4 plays a role in the regulation of sphingolipid metabolism. Since the accumulation of long chain sphingoid bases (LCBs) and the LCB-activated protein kinase Pkh1 have been implicated in ncr1Δ phenotypes [17], we also investigated how SIT4 deletion affects the levels of dihydrosphingosine (DHS), phytosphingosine (PHS) and its phosphorylated forms (DHS-1-P and PHS-1-P). LCBs increased in sit4Δ vs parental cells, due to the accumulation of DHS (in the exponential phase) or both DHS and PHS (in the PDS phase). In both growth phases, the levels of DHS-1-P and PHS-1-P also increased in sit4Δ cells (the increase was even higher, comparing to LCBs). Notably, ncr1Δsit4Δ cells exhibited similar changes (Table 3). Thus, SIT4 deletion seems to suppress ncr1Δ phenotypes by means unrelated with a decrease in LCBs.
Table 3. LCBs and LCB-1-Ps levels in cells grown to exponential and PDS phase.
Yeast cells were grown to exponential or post-diauxic shift (PDS) phase and sphingolipid levels were measured as described in Methods. Data are expressed as pmol/total cell number (mean ± SD of three independent experiments). The quantification in BY4741 and ncr1Δ cells [17] (reproduced here with permission) was paired with the quantification in sit4Δ and ncr1Δsit4Δ mutants (this study).
| Exponential phase | PDS phase | |||||||
|---|---|---|---|---|---|---|---|---|
| Strain | DHS* | DHS-1-P | PHS | PHS-1-P* | DHS* | DHS-1-P | PHS* | PHS-1-P* |
| BY4741 | 123.54±13.96 | 2.95±0.93 | 17.08±0.29 | 0.63±0.05 | 50.53±3.85 | 0.73±0.13 | 28.84±2.91 | 1.35±0.18 |
| ncr1Δ | 153.35±32.35 | 11.51±0.94 | 24.05±6.47 | 1.62±0.09 | 129.03±4.58 | 1.01±0.29 | 55.90±6.28 | 2.01±0.28 |
| sit4Δ | 195.74±11,70 | 21.44±1.13 | 18.96±2.08 | 1.87±0.10 | 266.79±124.48 | 6.46±2.15 | 101.34±5.87 | 5.19±0.45 |
| ncr1Δsit4Δ | 228.47±4.42 | 11.85±0.46 | 22.90±2.49 | 1.31±0.10 | 261.11±27.14 | 7.50±0.78 | 89.54±9.76 | 6.58±1.12 |
p<0.05, One-way ANOVA, non parametric test.
3.4. SIT4 deletion suppresses the activation of Pkh1-Sch9 pathway in ncr1Δ cells
Since Pkh1 is activated by LCBs and the levels of DHS (in the exponential phase) or both DHS and PHS (in the PDS phase) further increased in ncr1Δsit4Δ double mutants, compared with ncr1Δ cells, we decided to investigate the effect of SIT4 deletion on the activation of the Pkh1-Sch9 pathway in ncr1Δ cells. As previously shown [17], the levels of Sch9 and Sch9-phospho-T570 (Pkh1-dependent phosphorylation) increased in ncr1Δ cells. Notably, they greatly decreased in both sit4Δ and ncr1Δsit4Δ cells, when compared with parental and ncr1Δ cells (Fig. 6).
Figure 6. Sch9 and Sch9-phospho-T570 levels decrease drastically upon SIT4 deletion.
Yeast cells were grown in SC-glucose medium to exponential phase. Sch9 and phospho-T570-Sch9 levels were analyzed by immunoblotting, as described in Material and Methods. Pgk1 was used as loading control. A representative experiment out of three is shown.
In ncr1Δsit4Δ double mutants, the increase of LCB-1-Ps was higher to the observed for LCBs. Thus, we postulated that LCB-1-Ps could mediate the cellular effects of SIT4 deletion in ncr1Δ cells. To test this hypothesis, the LCB4 gene, which encodes for the major LCB kinase in yeast, was deleted. Our results show that the levels of Sch9 and Sch9-phospho-T570 increased in sit4Δlcb4Δ and ncr1Δsit4Δlcb4Δ mutants, compared with sit4Δ or ncr1Δsit4Δ cells, although to levels significantly lower to the observed in parental or ncr1Δ cells (Fig. 6). Consistently, ncr1Δsit4Δlcb4Δ mutants were still able to grow on glycerol medium (data not shown), suggesting that SIT4 deletion improves ncr1Δ phenotypes by a LCB-1-P-independent mechanism. Moreover, the deletion of DPL1, which encodes for the LCB-1-P lyase, did not suppress the mitochondrial dysfunction of ncr1Δ cells (data not shown), suggesting that the mitochondrial dysfunction of ncr1Δ cells is not related with the decrease of LCB-1-P levels. The overall results indicate that the protective effect of SIT4 deletion in ncr1Δ cells is mainly associated with downregulation of the Pkh1-Sch9 pathway.
4. Discussion
The Niemann-Pick type C1 disease is a lysosomal storage disorder caused by mutations in the NPC1 protein, which seems to be involved in the transport of cholesterol through the endolysosomal system. Several studies have shown a high degree of complexity of lipids that accumulate in NPC1 cells, including cholesterol, complex lipids such as glycosphingolipids and sphingomyelin [65], as well as sphingosine, which was suggested to be the first lipid that accumulates in these cells [14].
We have previously reported that, similarly to NPC1 cells, yeast cells lacking Ncr1 accumulate LCBs. This may contribute to the activation of the Pkh1-Sch9 pathway that ultimately contributes to mitochondrial dysfunctions, oxidative stress sensitivity and a shortened CLS [17]. Here we show that yeast ncr1Δ cells grown to PDS (respiratory) phase also exhibit significant changes in ceramide levels. These include a decrease in LC dhCer and an increase in LC phytoCer. Our data also demonstrate that both ceramide synthases and ceramidases genes are upregulated in ncr1Δ cells, with the LAG1 ceramide synthase being highly induced. These changes seem to favor phytoCer accumulation in ncr1Δ cells and may also contribute to the increase of LCBs promoted by the ceramidases. However, the mitochondrial defects exhibited by this mutant was not suppressed by deletion of the LAG1 ceramide synthase or ceramidases (YPC1, YDC1 or both) genes (data not shown). It is to be expected that modulations in any of the sphingolipid enzymes cause ripple effects that alter the concentrations of many sphingolipids. So, it is possible that the downregulation of Lag1 or ceramidases increases the levels of LCBs and ceramides, respectively, leading to further activation of downstream signaling pathways, which are known to promote mitochondrial dysfunctions [17, 52]. The inhibition of SPT (catalyzes the first step in sphingolipid biosynthesis) with low doses of myriocin also did not alleviate ncr1Δ phenotypes [17]. However, myriocin induces autophagy in ncr1Δ cells, which is probably detrimental since this process is already increased in untreated cells (data not shown) as described in NPC1 cells [66].
Ceramide constitutes the metabolic hub in sphingolipid metabolism since it is the core lipid that drives the synthesis of more than 50 distinct molecular species. Ceramides with different fatty acids have distinct roles as signaling molecules, acting through modulation of specific downstream components of signaling pathways, including CAPP [1]. Here we show that Sit4, the catalytic subunit of the CAPP related to type 2A family of protein phosphatases, was more activated in Ncr1-deficient cells. Moreover, the deletion of genes encoding for the catalytic (Sit4) or regulatory subunit (Cdc55) of CAPP abolished the shortened CLS, H2O2 hypersensitivity and mitochondrial dysfunctions displayed by ncr1Δ cells. Also, deletion of SUR2, which encodes for C4-hydroxylase responsible for generation of phytosphingosine and phytoceramides (Fig. 1), suppressed the shortened lifespan and mitochondrial defects of ncr1Δ cells. These findings support our hypothesis that phytoceramides are key mediators of sphingolipid signaling in ncr1Δ cells, promoting, at least in part, CAPP/Sit4 activation.
Previous studies have shown that Sit4 is involved in catabolic repression and negatively regulates mitochondrial function [42, 43]. In addition, sit4Δ cells exhibit a higher resistance to oxidative stress and an increased lifespan [52]. Thus, we propose that Sit4 activation mediates the mitochondrial defects of ncr1Δ cells, decreasing hydrogen peroxide resistance and CLS. It is likely that Sit4 affects mitochondria function through modulation of mitochondrial proteins or other proteins related to mitochondrial function and dynamics. Consistent with this hypothesis, published work has shown that Sit4 interacts with Atp3 (subunit of the ATP synthase) and Nde1 (external NADH dehydrogenase), and a mutation in Atp3 or NDE1 deletion increase CLS [67, 68]. The identification of Sit4 direct targets will provide new hints to the elucidation of how Sit4 regulates mitochondria and lifespan.
Importantly, our results suggest that Sit4 may also function as a modulator of sphingolipid homeostasis and dynamics. The deletion of SIT4 gene suppressed the lower levels of dhCer in ncr1Δ cells. This effect may contribute to the improvement of mitochondrial fitness in ncr1Δsit4Δ cells, since dhCer can exert protective effects by inhibiting the assembly of ceramide channels in mitochondria [69]. In contrast, long chain phytoceramides species were significantly increased in sit4Δ and ncr1Δsit4Δ cells. Notably, similar effects were observed upon deletion of SCH9 (data not shown), which also suppresses ncr1Δ phenotypes [17]. More studies are needed to uncover downstream effects mediated by these specific ceramide species as well as its subcellular localization.
We have previously shown that SCH9 deletion suppresses the high levels of LCBs displayed by ncr1Δ cells [17]. Notably, sit4Δ and ncr1Δsit4Δ cells exhibited major changes in LCBs. The levels of PHS and DHS increased in these mutants concomitantly with a higher increase of their 1-phosphate forms, leading to an increase of DHS-1-P/DHS and PHS-1-P/PHS ratios. Although the increase of LCB-1-phosphates has been associated with inhibition of cell death pathways [2], our results suggest that it does not contribute to cellular effects of SIT4 deletion. LCBs are known activators of the Pkh1 and Pkh2 protein kinases [70] that activate the Sch9 kinase by phosphorylating a T570 residue [71, 72]. Our results show that Sch9 and Sch9-phospho-T570 levels decrease in ncr1Δsit4Δ cells, suggesting that the protective effect of SIT4 deletion is, at least in part, mediated by downregulation of the Pkh1-Sch9 pathway. This crosstalk between Sit4 and Pkh1/2-Sch9 seems to be conserved in mammals. Indeed, mammalian Akt/PKB, a homologue of yeast Sch9, is inhibited by ceramide by a CAPP-dependent mechanism [73, 74]. More studies are needed to uncover the molecular mechanisms underlying the intricate regulation of these pathways and its relation with other protein kinases and protein phosphatases that control sphingolipid biosynthesis, e.g. through modulation of Orm1/2 by Ypk1 [75–77].
In summary, our results suggest that the accumulation of phytoceramide species leading to activation of the ceramide activated protein phosphatase Sit4 and the crosstalk between Sit4 and Sch9 mediate the mitochondrial defects, premature ageing and oxidative stress sensitivity displayed by the yeast model of Niemann-Pick type C1 disease (Fig. 7). To our knowledge, this is the first report implicating ceramide signaling in NPC1 phenotypes.
Figure 7. Activation and cross-talk of LCB and ceramide signaling pathways in the NPC1 yeast model.
Deletion of yeast NPC1 related protein induces high levels of LCBs, particularly phytosphingosine (PHS) [17], and long chain phytoceramide species (this study). Ceramide signaling targets the ceramide-activated protein phosphatase (CAPP) Sit4 that mediates mitochondrial dysfunction and decreases cellular lifespan in ncr1Δ cells. Sit4 also regulates Sch9 levels and Pkh1-dependent phosphorylation which also contributes to ncr1Δ phenotypes, by an unknown mechanism [17].
Supplementary Material
Highlights.
The yeast model of Niemann-Pick type C1 (ncr1Δ) accumulates phytoceramides
The ceramide activated protein phosphatase Sit4 is stimulated in ncr1Δ cells
Sit4 activation impairs mitochondrial function and decreases ncr1Δ lifespan
SIT4 deletion leads to downregulation of the Sch9 protein kinase
Acknowledgments
We are grateful to Bruno André (Université Libre de Bruxelles, Belgium), Paula Ludovico (ICVS, Universidade do Minho, Portugal), Joris Winderickx (Inst. Botany and Microbiology, K.U. Leuven, Belgium), Robert Dickson (University of Kentucky College of Medicine, Lexington, Kentucky, USA), Robbie Loewith (University of Geneva, Switzerland) and Yu Jiang (University of Pittsburgh, USA) for generously providing plasmids and antibodies used in this study. We would like to thank Paula Sampaio (ALM, IBMC/I3S) for technical assistance and data treatment on fluorescence microscopy. This work was funded by the project Norte-01-0145-FEDER-000008 - Porto Neurosciences and Neurologic Disease Research Initiative at I3S, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (FEDER), and in part by National Institutes of Health Grant GM063265 (to Y.A.H.), the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313) and the Lipidomics Core in the SC Lipidomics and Pathobiology COBRE, Department Biochemistry, MUSC (P20 RR017677).
Abbreviations
- CAPP
ceramide-activated protein phosphatase
- CLS
chronological lifespan
- COX
cytochrome c oxidase
- dhCer
dihydroceramide
- DHS
dihydrosphingosine
- LCB
long chain sphingoid base
- MAPK
mitogen activated protein kinase
- NPC
Niemann-Pick type C
- PDS
post-diauxic shift
- phytoCer
phytoceramide
- PHS
phytosphingosine
- ROS
reactive oxygen species
Footnotes
Competing interests
No competing interests declared.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008;9:139–150. doi: 10.1038/nrm2329. [DOI] [PubMed] [Google Scholar]
- 2.Hannun YA, Obeid LM. Many ceramides. J Biol Chem. 2011;286:27855–27862. doi: 10.1074/jbc.R111.254359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.van Echten-Deckert G, Walter J. Sphingolipids: critical players in Alzheimer’s disease. Prog Lipid Res. 2012;51:378–393. doi: 10.1016/j.plipres.2012.07.001. [DOI] [PubMed] [Google Scholar]
- 4.Bras J, Singleton A, Cookson MR, Hardy J. Emerging pathways in genetic Parkinson’s disease: Potential role of ceramide metabolism in Lewy body disease. FEBS J. 2008;275:5767–5773. doi: 10.1111/j.1742-4658.2008.06709.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gatt S, Dagan A. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids. Chem Phys Lipids. 2012;165:462–474. doi: 10.1016/j.chemphyslip.2012.02.006. [DOI] [PubMed] [Google Scholar]
- 6.Kolter T, Sandhoff K. Lysosomal degradation of membrane lipids. FEBS Lett. 2010;584:1700–1712. doi: 10.1016/j.febslet.2009.10.021. [DOI] [PubMed] [Google Scholar]
- 7.Liscum L. Niemann-Pick type C mutations cause lipid traffic jam. Traffic. 2000;1:218–225. doi: 10.1034/j.1600-0854.2000.010304.x. [DOI] [PubMed] [Google Scholar]
- 8.Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, Nagle J, Polymeropoulos MH, Sturley SL, Ioannou YA, Higgins ME, Comly M, Cooney A, Brown A, Kaneski CR, Blanchette-Mackie EJ, Dwyer NK, Neufeld EB, Chang TY, Liscum L, Strauss JF, 3rd, Ohno K, Zeigler M, Carmi R, Sokol J, Markie D, O’Neill RR, van Diggelen OP, Elleder M, Patterson MC, Brady RO, Vanier MT, Pentchev PG, Tagle DA. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science. 1997;277:228–231. doi: 10.1126/science.277.5323.228. [DOI] [PubMed] [Google Scholar]
- 9.Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, Jadot M, Lobel P. Identification of HE1 as the second gene of Niemann-Pick C disease. Science. 2000;290:2298–2301. doi: 10.1126/science.290.5500.2298. [DOI] [PubMed] [Google Scholar]
- 10.Higgins ME, Davies JP, Chen FW, Ioannou YA. Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Mol Genet Metab. 1999;68:1–13. doi: 10.1006/mgme.1999.2882. [DOI] [PubMed] [Google Scholar]
- 11.Ko DC, Binkley J, Sidow A, Scott MP. The integrity of a cholesterol-binding pocket in Niemann-Pick C2 protein is necessary to control lysosome cholesterol levels. Proc Natl Acad Sci U S A. 2003;100:2518–2525. doi: 10.1073/pnas.0530027100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Kwon HJ, Abi-Mosleh L, Wang ML, Deisenhofer J, Goldstein JL, Brown MS, Infante RE. Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell. 2009;137:1213–1224. doi: 10.1016/j.cell.2009.03.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Vanier MT. Lipid Changes in Niemann-Pick Disease Type C Brain: Personal Experience and Review of the Literature. Neurochemical Research. 1999;24:481–489. doi: 10.1023/a:1022575511354. [DOI] [PubMed] [Google Scholar]
- 14.Lloyd-Evans E, Morgan AJ, He X, Smith DA, Elliot-Smith E, Sillence DJ, Churchill GC, Schuchman EH, Galione A, Platt FM. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat Med. 2008;14:1247–1255. doi: 10.1038/nm.1876. [DOI] [PubMed] [Google Scholar]
- 15.Megyeri M, Riezman H, Schuldiner M, Futerman AH. Making Sense of the Yeast Sphingolipid Pathway. Journal of Molecular Biology. 2016;428:4765–4775. doi: 10.1016/j.jmb.2016.09.010. [DOI] [PubMed] [Google Scholar]
- 16.Malathi K, Higaki K, Tinkelenberg AH, Balderes DA, Almanzar-Paramio D, Wilcox LJ, Erdeniz N, Redican F, Padamsee M, Liu Y, Khan S, Alcantara F, Carstea ED, Morris JA, Sturley SL. Mutagenesis of the putative sterol-sensing domain of yeast Niemann Pick C-related protein reveals a primordial role in subcellular sphingolipid distribution. J Cell Biol. 2004;164:547–556. doi: 10.1083/jcb.200310046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Vilaça R, Silva E, Nadais A, Teixeira V, Matmati N, Gaifem J, Hannun YA, Sa Miranda MC, Costa V. Sphingolipid signaling mediates mitochondrial dysfunctions and reduced chronological lifespan in the yeast model of Niemann-Pick type C1. Mol Microbiol. 2014;91:438–451. doi: 10.1111/mmi.12470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Dickson RC. Sphingolipid functions in Saccharomyces cerevisiae: comparison to mammals. Annu Rev Biochem. 1998;67:27–48. doi: 10.1146/annurev.biochem.67.1.27. [DOI] [PubMed] [Google Scholar]
- 19.Van Brocklyn JR, Williams JB. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death. Comp Biochem Physiol B Biochem Mol Biol. 2012;163:26–36. doi: 10.1016/j.cbpb.2012.05.006. [DOI] [PubMed] [Google Scholar]
- 20.D’Mello PN, Childress AM, Franklin DS, Kale SP, Pinswasdi C, Jazwinski SM. Cloning and characterization of LAG1, a longevity-assurance gene in yeast. J Biol Chem. 1994;269:15451–15459. [PubMed] [Google Scholar]
- 21.Jiang JC, Kirchman PA, Allen M, Jazwinski SM. Suppressor analysis points to the subtle role of the LAG1 ceramide synthase gene in determining yeast longevity. Exp Gerontol. 2004;39:999–1009. doi: 10.1016/j.exger.2004.03.026. [DOI] [PubMed] [Google Scholar]
- 22.Aerts AM, Zabrocki P, Francois IE, Carmona-Gutierrez D, Govaert G, Mao C, Smets B, Madeo F, Winderickx J, Cammue BP, Thevissen K. Ydc1p ceramidase triggers organelle fragmentation, apoptosis and accelerated ageing in yeast. Cell Mol Life Sci. 2008;65:1933–1942. doi: 10.1007/s00018-008-8129-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Lester RL, Withers BR, Schultz MA, Dickson RC. Iron glucose and intrinsic factors alter sphingolipid composition as yeast cells enter stationary phase. Biochim Biophys Acta. 2013;1831:726–736. doi: 10.1016/j.bbalip.2012.12.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Huang X, Liu J, Dickson RC. Down-regulating sphingolipid synthesis increases yeast lifespan. PLoS Genet. 2012;8:e1002493. doi: 10.1371/journal.pgen.1002493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Toda T, Cameron S, Sass P, Wigler M. SCH9, a gene of Saccharomyces cerevisiae that encodes a protein distinct from, but functionally and structurally related to, cAMP-dependent protein kinase catalytic subunits. Genes Dev. 1988;2:517–527. doi: 10.1101/gad.2.5.517. [DOI] [PubMed] [Google Scholar]
- 26.Urban J, Soulard A, Huber A, Lippman S, Mukhopadhyay D, Deloche O, Wanke V, Anrather D, Ammerer G, Riezman H, Broach JR, De Virgilio C, Hall MN, Loewith R. Sch9 is a major target of TORC1 in Saccharomyces cerevisiae. Mol Cell. 2007;26:663–674. doi: 10.1016/j.molcel.2007.04.020. [DOI] [PubMed] [Google Scholar]
- 27.Almeida T, Marques M, Mojzita D, Amorim MA, Silva RD, Almeida B, Rodrigues P, Ludovico P, Hohmann S, Moradas-Ferreira P, Corte-Real M, Costa V. Isc1p plays a key role in hydrogen peroxide resistance and chronological lifespan through modulation of iron levels and apoptosis. Mol Biol Cell. 2008;19:865–876. doi: 10.1091/mbc.E07-06-0604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Vanier MT. Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen. Biochimica et biophysica acta. 1983;750:178–184. doi: 10.1016/0005-2760(83)90218-7. [DOI] [PubMed] [Google Scholar]
- 29.Lige B, Romano JD, Bandaru VV, Ehrenman K, Levitskaya J, Sampels V, Haughey NJ, Coppens I. Deficiency of a Niemann-Pick, type C1-related protein in toxoplasma is associated with multiple lipidoses and increased pathogenicity. PLoS Pathog. 2011;7:e1002410. doi: 10.1371/journal.ppat.1002410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Gulbins E, Kolesnick R. Raft ceramide in molecular medicine. Oncogene. 2003;22:7070–7077. doi: 10.1038/sj.onc.1207146. [DOI] [PubMed] [Google Scholar]
- 31.Ruvolo PP. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol Res. 2003;47:383–392. doi: 10.1016/s1043-6618(03)00050-1. [DOI] [PubMed] [Google Scholar]
- 32.Dobrowsky RT, Kamibayashi C, Mumby MC, Hannun YA. Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem. 1993;268:15523–15530. [PubMed] [Google Scholar]
- 33.Galadari S, Kishikawa K, Kamibayashi C, Mumby MC, Hannun YA. Purification and characterization of ceramide-activated protein phosphatases. Biochemistry. 1998;37:11232–11238. doi: 10.1021/bi980911+. [DOI] [PubMed] [Google Scholar]
- 34.Chalfant CE, Kishikawa K, Mumby MC, Kamibayashi C, Bielawska A, Hannun YA. Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid. J Biol Chem. 1999;274:20313–20317. doi: 10.1074/jbc.274.29.20313. [DOI] [PubMed] [Google Scholar]
- 35.Chalfant CE, Szulc Z, Roddy P, Bielawska A, Hannun YA. The structural requirements for ceramide activation of serine-threonine protein phosphatases. J Lipid Res. 2004;45:496–506. doi: 10.1194/jlr.M300347-JLR200. [DOI] [PubMed] [Google Scholar]
- 36.Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J. 2001;353:417–439. doi: 10.1042/0264-6021:3530417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Fishbein JD, Dobrowsky RT, Bielawska A, Garrett S, Hannun YA. Ceramide-mediated growth inhibition and CAPP are conserved in Saccharomyces cerevisiae. J Biol Chem. 1993;268:9255–9261. [PubMed] [Google Scholar]
- 38.Nickels JT, Broach JR. A ceramide-activated protein phosphatase mediates ceramide-induced G1 arrest of Saccharomyces cerevisiae. Genes Dev. 1996;10:382–394. doi: 10.1101/gad.10.4.382. [DOI] [PubMed] [Google Scholar]
- 39.Bastians H, Ponstingl H. The novel human protein serine/threonine phosphatase 6 is a functional homologue of budding yeast Sit4p and fission yeast ppe1, which are involved in cell cycle regulation. J Cell Sci. 1996;109(Pt 12):2865–2874. doi: 10.1242/jcs.109.12.2865. [DOI] [PubMed] [Google Scholar]
- 40.Fernandez-Sarabia MJ, Sutton A, Zhong T, Arndt KT. SIT4 protein phosphatase is required for the normal accumulation of SWI4, CLN1, CLN2, and HCS26 RNAs during late G1. Genes Dev. 1992;6:2417–2428. doi: 10.1101/gad.6.12a.2417. [DOI] [PubMed] [Google Scholar]
- 41.Arndt KT, Styles CA, Fink GR. A suppressor of a HIS4 transcriptional defect encodes a protein with homology to the catalytic subunit of protein phosphatases. Cell. 1989;56:527–537. doi: 10.1016/0092-8674(89)90576-x. [DOI] [PubMed] [Google Scholar]
- 42.Jablonka W, Guzman S, Ramirez J, Montero-Lomeli M. Deviation of carbohydrate metabolism by the SIT4 phosphatase in Saccharomyces cerevisiae. Biochim Biophys Acta. 2006;1760:1281–1291. doi: 10.1016/j.bbagen.2006.02.014. [DOI] [PubMed] [Google Scholar]
- 43.Jin C, Barrientos A, Epstein CB, Butow RA, Tzagoloff A. SIT4 regulation of Mig1p-mediated catabolite repression in Saccharomyces cerevisiae. FEBS Lett. 2007;581:5658–5663. doi: 10.1016/j.febslet.2007.11.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.de Assis LJ, Zingali RB, Masuda CA, Rodrigues SP, Montero-Lomeli M. Pyruvate decarboxylase activity is regulated by the Ser/Thr protein phosphatase Sit4p in the yeast Saccharomyces cerevisiae. FEMS Yeast Res. 2013;13:518–528. doi: 10.1111/1567-1364.12052. [DOI] [PubMed] [Google Scholar]
- 45.Posas F, Clotet J, Arino J. Saccharomyces cerevisiae gene SIT4 is involved in the control of glycogen metabolism. FEBS Lett. 1991;279:341–345. doi: 10.1016/0014-5793(91)80183-4. [DOI] [PubMed] [Google Scholar]
- 46.Masuda CA, Ramirez J, Pena A, Montero-Lomeli M. Regulation of monovalent ion homeostasis and pH by the Ser-Thr protein phosphatase SIT4 in Saccharomyces cerevisiae. J Biol Chem. 2000;275:30957–30961. doi: 10.1074/jbc.M004869200. [DOI] [PubMed] [Google Scholar]
- 47.Angeles de la Torre-Ruiz M, Torres J, Arino J, Herrero E. Sit4 is required for proper modulation of the biological functions mediated by Pkc1 and the cell integrity pathway in Saccharomyces cerevisiae. J Biol Chem. 2002;277:33468–33476. doi: 10.1074/jbc.M203515200. [DOI] [PubMed] [Google Scholar]
- 48.Bhandari D, Zhang J, Menon S, Lord C, Chen S, Helm JR, Thorsen K, Corbett KD, Hay JC, Ferro-Novick S. Sit4p/PP6 regulates ER-to-Golgi traffic by controlling the dephosphorylation of COPII coat subunits. Mol Biol Cell. 2013;24:2727–2738. doi: 10.1091/mbc.E13-02-0114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Di Como CJ, Arndt KT. Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases. Genes Dev. 1996;10:1904–1916. doi: 10.1101/gad.10.15.1904. [DOI] [PubMed] [Google Scholar]
- 50.Wang H, Wang X, Jiang Y. Interaction with Tap42 is required for the essential function of Sit4 and type 2A phosphatases. Mol Biol Cell. 2003;14:4342–4351. doi: 10.1091/mbc.E03-02-0072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Castellano BM, Thelen AM, Moldavski O, Feltes M, van der Welle REN, Mydock-McGrane L, Jiang X, van Eijkeren RJ, Davis OB, Louie SM, Perera RM, Covey DF, Nomura DK, Ory DS, Zoncu R. Lysosomal cholesterol activates mTORC1 via an SLC38A9–Niemann-Pick C1 signaling complex. Science. 2017;355:1306–1311. doi: 10.1126/science.aag1417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Barbosa AD, Osorio H, Sims KJ, Almeida T, Alves M, Bielawski J, Amorim MA, Moradas-Ferreira P, Hannun YA, Costa V. Role for Sit4p-dependent mitochondrial dysfunction in mediating the shortened chronological lifespan and oxidative stress sensitivity of Isc1p-deficient cells. Mol Microbiol. 2011;81:515–527. doi: 10.1111/j.1365-2958.2011.07714.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Barbosa AD, Graca J, Mendes V, Chaves SR, Amorim MA, Mendes MV, Moradas-Ferreira P, Corte-Real M, Costa V. Activation of the Hog1p kinase in Isc1p-deficient yeast cells is associated with mitochondrial dysfunction, oxidative stress sensitivity and premature aging. Mech Ageing Dev. 2012;133:317–330. doi: 10.1016/j.mad.2012.03.007. [DOI] [PubMed] [Google Scholar]
- 54.Teixeira V, Medeiros T, Vilaca R, Moradas-Ferreira P, Costa V. Reduced TORC1 signaling abolishes mitochondrial dysfunctions and shortened chronological lifespan of Isc1p-deficient cells. Microbial Cell. 2014;1:21–36. doi: 10.15698/mic2014.01.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Swinnen E, Wilms T, Idkowiak-Baldys J, Smets B, De Snijder P, Accardo S, Ghillebert R, Thevissen K, Cammue B, De Vos D, Bielawski J, Hannun YA, Winderickx J. The protein kinase Sch9 is a key regulator of sphingolipid metabolism in Saccharomyces cerevisiae. Mol Biol Cell. 2014;25:196–211. doi: 10.1091/mbc.E13-06-0340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Woodacre A, Lone MA, Jablonowski D, Schneiter R, Giorgini F, Schaffrath R. A novel Sit4 phosphatase complex is involved in the response to ceramide stress in yeast. Oxid Med Cell Longev. 2013;2013:129645. doi: 10.1155/2013/129645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Agatep R, Kirkpatrick RD, Parchaliuk DL, Woods RA, Gietz RD. Transformation of Saccharomyces cerevisiae by the lithium acetate/single-stranded carrier DNA/polyethylene glycol protocol. Technical Tips Online. 1998;3:133–137. [Google Scholar]
- 58.Marini AM, Soussi-Boudekou S, Vissers S, Andre B. A family of ammonium transporters in Saccharomyces cerevisiae. Mol Cell Biol. 1997;17:4282–4293. doi: 10.1128/mcb.17.8.4282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Schauss AC, Bewersdorf J, Jakobs S. Fis1p and Caf4p, but not Mdv1p, determine the polar localization of Dnm1p clusters on the mitochondrial surface. J Cell Sci. 2006;119:3098–3106. doi: 10.1242/jcs.03026. [DOI] [PubMed] [Google Scholar]
- 60.Bielawski J, Pierce JS, Snider J, Rembiesa B, Szulc ZM, Bielawska A. Sphingolipid analysis by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) Adv Exp Med Biol. 2010;688:46–59. doi: 10.1007/978-1-4419-6741-1_3. [DOI] [PubMed] [Google Scholar]
- 61.Mesquita A, Weinberger M, Silva A, Sampaio-Marques B, Almeida B, Leao C, Costa V, Rodrigues F, Burhans WC, Ludovico P. Caloric restriction or catalase inactivation extends yeast chronological lifespan by inducing H2O2 and superoxide dismutase activity. Proc Natl Acad Sci U S A. 2010;107:15123–15128. doi: 10.1073/pnas.1004432107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Poyton RO, Goehring B, Droste M, Sevarino KA, Allen LA, Zhao XJ. Cytochrome-c oxidase from Saccharomyces cerevisiae. Methods Enzymol. 1995;260:97–116. doi: 10.1016/0076-6879(95)60133-3. [DOI] [PubMed] [Google Scholar]
- 63.Kitagaki H, Cowart LA, Matmati N, Vaena de Avalos S, Novgorodov SA, Zeidan YH, Bielawski J, Obeid LM, Hannun YA. Isc1 regulates sphingolipid metabolism in yeast mitochondria. Biochim Biophys Acta. 2007;1768:2849–2861. doi: 10.1016/j.bbamem.2007.07.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Tate JJ, Feller A, Dubois E, Cooper TG. Saccharomyces cerevisiae Sit4 phosphatase is active irrespective of the nitrogen source provided, and Gln3 phosphorylation levels become nitrogen source-responsive in a sit4-deleted strain. J Biol Chem. 2006;281:37980–37992. doi: 10.1074/jbc.M606973200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Vanier MT. Complex lipid trafficking in Niemann-Pick disease type C. J Inherit Metab Dis. 2015;38:187–199. doi: 10.1007/s10545-014-9794-4. [DOI] [PubMed] [Google Scholar]
- 66.Ishibashi S, Yamazaki T, Okamoto K. Association of autophagy with cholesterol-accumulated compartments in Niemann-Pick disease type C cells. J Clin Neurosci. 2009;16:954–959. doi: 10.1016/j.jocn.2008.09.020. [DOI] [PubMed] [Google Scholar]
- 67.Li W, Sun L, Liang Q, Wang J, Mo W, Zhou B. Yeast AMID homologue Ndi1p displays respiration-restricted apoptotic activity and is involved in chronological aging. Mol Biol Cell. 2006;17:1802–1811. doi: 10.1091/mbc.E05-04-0333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Francis BR, White KH, Thorsness PE. Mutations in the Atp1p and Atp3p subunits of yeast ATP synthase differentially affect respiration and fermentation in Saccharomyces cerevisiae. J Bioenerg Biomembr. 2007;39:127–144. doi: 10.1007/s10863-007-9071-4. [DOI] [PubMed] [Google Scholar]
- 69.Stiban J, Fistere D, Colombini M. Dihydroceramide hinders ceramide channel formation: Implications on apoptosis. Apoptosis. 2006;11:773–780. doi: 10.1007/s10495-006-5882-8. [DOI] [PubMed] [Google Scholar]
- 70.Liu K, Zhang X, Lester RL, Dickson RC. The sphingoid long chain base phytosphingosine activates AGC-type protein kinases in Saccharomyces cerevisiae including Ypk1, Ypk2, and Sch9. J Biol Chem. 2005;280:22679–22687. doi: 10.1074/jbc.M502972200. [DOI] [PubMed] [Google Scholar]
- 71.Roelants FM, Torrance PD, Thorner J. Differential roles of PDK1- and PDK2-phosphorylation sites in the yeast AGC kinases Ypk1, Pkc1 and Sch9. Microbiology. 2004;150:3289–3304. doi: 10.1099/mic.0.27286-0. [DOI] [PubMed] [Google Scholar]
- 72.Voordeckers K, Kimpe M, Haesendonckx S, Louwet W, Versele M, Thevelein JM. Yeast 3-phosphoinositide-dependent protein kinase-1 (PDK1) orthologs Pkh1-3 differentially regulate phosphorylation of protein kinase A (PKA) and the protein kinase B (PKB)/S6K ortholog Sch9. J Biol Chem. 2011;286:22017–22027. doi: 10.1074/jbc.M110.200071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Salinas M, Lopez-Valdaliso R, Martin D, Alvarez A, Cuadrado A. Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells. Mol Cell Neurosci. 2000;15:156–169. doi: 10.1006/mcne.1999.0813. [DOI] [PubMed] [Google Scholar]
- 74.Ghosh N, Patel N, Jiang K, Watson JE, Cheng J, Chalfant CE, Cooper DR. Ceramide-activated protein phosphatase involvement in insulin resistance via Akt, serine/arginine-rich protein 40, and ribonucleic acid splicing in L6 skeletal muscle cells. Endocrinology. 2007;148:1359–1366. doi: 10.1210/en.2006-0750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Roelants FM, Breslow DK, Muir A, Weissman JS, Thorner J. Protein kinase Ypk1 phosphorylates regulatory proteins Orm1 and Orm2 to control sphingolipid homeostasis in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 2011;108:19222–19227. doi: 10.1073/pnas.1116948108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Liu M, Huang C, Polu SR, Schneiter R, Chang A. Regulation of sphingolipid synthesis through Orm1 and Orm2 in yeast. J Cell Sci. 2012;125:2428–2435. doi: 10.1242/jcs.100578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Shimobayashi M, Oppliger W, Moes S, Jeno P, Hall MN. TORC1-regulated protein kinase Npr1 phosphorylates Orm to stimulate complex sphingolipid synthesis. Mol Biol Cell. 2013;24:870–881. doi: 10.1091/mbc.E12-10-0753. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.







